Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.06
SNN's Cash to Debt is ranked lower than
96% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: 2.56 vs. SNN: 0.06 )
Ranked among companies with meaningful Cash to Debt only.
SNN' s 10-Year Cash to Debt Range
Min: 0.06  Med: 0.17 Max: 2.58
Current: 0.06
0.06
2.58
Equity to Asset 0.55
SNN's Equity to Asset is ranked lower than
62% of the 282 Companies
in the Global Medical Devices industry.

( Industry Median: 0.66 vs. SNN: 0.55 )
Ranked among companies with meaningful Equity to Asset only.
SNN' s 10-Year Equity to Asset Range
Min: 0.34  Med: 0.52 Max: 0.7
Current: 0.55
0.34
0.7
Interest Coverage 21.40
SNN's Interest Coverage is ranked lower than
75% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 10000.00 vs. SNN: 21.40 )
Ranked among companies with meaningful Interest Coverage only.
SNN' s 10-Year Interest Coverage Range
Min: 7.79  Med: 17.21 Max: 81
Current: 21.4
7.79
81
F-Score: 6
Z-Score: 4.96
M-Score: -2.65
WACC vs ROIC
8.43%
10.03%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 16.26
SNN's Operating margin (%) is ranked higher than
83% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 3.12 vs. SNN: 16.26 )
Ranked among companies with meaningful Operating margin (%) only.
SNN' s 10-Year Operating margin (%) Range
Min: 12.6  Med: 16.22 Max: 23.22
Current: 16.26
12.6
23.22
Net-margin (%) 10.89
SNN's Net-margin (%) is ranked higher than
81% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 1.99 vs. SNN: 10.89 )
Ranked among companies with meaningful Net-margin (%) only.
SNN' s 10-Year Net-margin (%) Range
Min: 8.9  Med: 12.51 Max: 26.81
Current: 10.89
8.9
26.81
ROE (%) 12.30
SNN's ROE (%) is ranked higher than
77% of the 287 Companies
in the Global Medical Devices industry.

( Industry Median: 3.14 vs. SNN: 12.30 )
Ranked among companies with meaningful ROE (%) only.
SNN' s 10-Year ROE (%) Range
Min: 12.67  Med: 23.89 Max: 47.17
Current: 12.3
12.67
47.17
ROA (%) 7.30
SNN's ROA (%) is ranked higher than
75% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: -0.22 vs. SNN: 7.30 )
Ranked among companies with meaningful ROA (%) only.
SNN' s 10-Year ROA (%) Range
Min: 7.79  Med: 11.52 Max: 22.64
Current: 7.3
7.79
22.64
ROC (Joel Greenblatt) (%) 36.21
SNN's ROC (Joel Greenblatt) (%) is ranked higher than
83% of the 315 Companies
in the Global Medical Devices industry.

( Industry Median: 3.55 vs. SNN: 36.21 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
SNN' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 32.43  Med: 46.74 Max: 79.28
Current: 36.21
32.43
79.28
Revenue Growth (3Y)(%) 2.50
SNN's Revenue Growth (3Y)(%) is ranked lower than
52% of the 193 Companies
in the Global Medical Devices industry.

( Industry Median: 3.00 vs. SNN: 2.50 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
SNN' s 10-Year Revenue Growth (3Y)(%) Range
Min: 1  Med: 8.90 Max: 37.2
Current: 2.5
1
37.2
EBITDA Growth (3Y)(%) 0.40
SNN's EBITDA Growth (3Y)(%) is ranked lower than
53% of the 170 Companies
in the Global Medical Devices industry.

( Industry Median: 2.10 vs. SNN: 0.40 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
SNN' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -2.4  Med: 13.95 Max: 36.3
Current: 0.4
-2.4
36.3
EPS Growth (3Y)(%) -4.90
SNN's EPS Growth (3Y)(%) is ranked lower than
54% of the 171 Companies
in the Global Medical Devices industry.

( Industry Median: -0.40 vs. SNN: -4.90 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
SNN' s 10-Year EPS Growth (3Y)(%) Range
Min: -8.2  Med: 14.35 Max: 57.3
Current: -4.9
-8.2
57.3
» SNN's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2014

SNN Guru Trades in Q3 2014

Mario Gabelli 15,350 sh (+59.07%)
Louis Moore Bacon 40,000 sh (+33.33%)
Jim Simons 171,800 sh (+20.14%)
Pioneer Investments 34,059 sh (unchged)
John Hussman 19,500 sh (unchged)
Steven Cohen Sold Out
David Dreman 74,325 sh (-0.74%)
Ken Fisher 973,153 sh (-28.52%)
» More
Q4 2014

SNN Guru Trades in Q4 2014

Pioneer Investments 84,570 sh (+148.30%)
John Hussman 48,750 sh (unchged)
Louis Moore Bacon Sold Out
Ken Fisher 2,291,837 sh (-5.80%)
Mario Gabelli 31,875 sh (-16.94%)
David Dreman 148,777 sh (-19.93%)
Jim Simons 343,850 sh (-19.94%)
» More
Q1 2015

SNN Guru Trades in Q1 2015

Eric Mindich 502,000 sh (New)
Ken Fisher 2,299,852 sh (+0.35%)
Pioneer Investments 84,570 sh (unchged)
Jim Simons 310,000 sh (-9.84%)
Mario Gabelli 25,875 sh (-18.82%)
David Dreman 117,479 sh (-21.04%)
John Hussman 15,000 sh (-69.23%)
» More
Q2 2015

SNN Guru Trades in Q2 2015

Ken Fisher 2,083,106 sh (-9.42%)
» More
» Details

Insider Trades

Latest Guru Trades with SNN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 33.45
SNN's P/E(ttm) is ranked lower than
59% of the 156 Companies
in the Global Medical Devices industry.

( Industry Median: 28.40 vs. SNN: 33.45 )
Ranked among companies with meaningful P/E(ttm) only.
SNN' s 10-Year P/E(ttm) Range
Min: 10.22  Med: 19.76 Max: 44.27
Current: 33.45
10.22
44.27
Forward P/E 15.04
SNN's Forward P/E is ranked higher than
78% of the 96 Companies
in the Global Medical Devices industry.

( Industry Median: 23.26 vs. SNN: 15.04 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 33.20
SNN's PE(NRI) is ranked lower than
58% of the 154 Companies
in the Global Medical Devices industry.

( Industry Median: 28.30 vs. SNN: 33.20 )
Ranked among companies with meaningful PE(NRI) only.
SNN' s 10-Year PE(NRI) Range
Min: 11.42  Med: 23.19 Max: 45.28
Current: 33.2
11.42
45.28
P/B 3.97
SNN's P/B is ranked lower than
61% of the 287 Companies
in the Global Medical Devices industry.

( Industry Median: 3.11 vs. SNN: 3.97 )
Ranked among companies with meaningful P/B only.
SNN' s 10-Year P/B Range
Min: 0.55  Med: 3.85 Max: 7.5
Current: 3.97
0.55
7.5
P/S 3.63
SNN's P/S is ranked lower than
56% of the 290 Companies
in the Global Medical Devices industry.

( Industry Median: 3.15 vs. SNN: 3.63 )
Ranked among companies with meaningful P/S only.
SNN' s 10-Year P/S Range
Min: 1.67  Med: 2.79 Max: 4.35
Current: 3.63
1.67
4.35
PFCF 52.06
SNN's PFCF is ranked lower than
76% of the 115 Companies
in the Global Medical Devices industry.

( Industry Median: 30.88 vs. SNN: 52.06 )
Ranked among companies with meaningful PFCF only.
SNN' s 10-Year PFCF Range
Min: 12.57  Med: 31.78 Max: 190.33
Current: 52.06
12.57
190.33
POCF 24.37
SNN's POCF is ranked lower than
56% of the 149 Companies
in the Global Medical Devices industry.

( Industry Median: 21.63 vs. SNN: 24.37 )
Ranked among companies with meaningful POCF only.
SNN' s 10-Year POCF Range
Min: 8.22  Med: 17.26 Max: 41.46
Current: 24.37
8.22
41.46
EV-to-EBIT 26.14
SNN's EV-to-EBIT is ranked lower than
59% of the 162 Companies
in the Global Medical Devices industry.

( Industry Median: 21.84 vs. SNN: 26.14 )
Ranked among companies with meaningful EV-to-EBIT only.
SNN' s 10-Year EV-to-EBIT Range
Min: 8.8  Med: 16.10 Max: 34.3
Current: 26.14
8.8
34.3
PEG 13.28
SNN's PEG is ranked lower than
84% of the 55 Companies
in the Global Medical Devices industry.

( Industry Median: 3.42 vs. SNN: 13.28 )
Ranked among companies with meaningful PEG only.
SNN' s 10-Year PEG Range
Min: 0.3  Med: 0.74 Max: 28.98
Current: 13.28
0.3
28.98
Shiller P/E 27.24
SNN's Shiller P/E is ranked higher than
59% of the 94 Companies
in the Global Medical Devices industry.

( Industry Median: 30.75 vs. SNN: 27.24 )
Ranked among companies with meaningful Shiller P/E only.
SNN' s 10-Year Shiller P/E Range
Min: 15.25  Med: 22.40 Max: 36.24
Current: 27.24
15.25
36.24
Current Ratio 2.10
SNN's Current Ratio is ranked lower than
61% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 2.71 vs. SNN: 2.10 )
Ranked among companies with meaningful Current Ratio only.
SNN' s 10-Year Current Ratio Range
Min: 0.84  Med: 1.67 Max: 2.4
Current: 2.1
0.84
2.4
Quick Ratio 1.08
SNN's Quick Ratio is ranked lower than
75% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 2.03 vs. SNN: 1.08 )
Ranked among companies with meaningful Quick Ratio only.
SNN' s 10-Year Quick Ratio Range
Min: 0.47  Med: 1.03 Max: 1.35
Current: 1.08
0.47
1.35
Days Inventory 354.48
SNN's Days Inventory is ranked lower than
90% of the 281 Companies
in the Global Medical Devices industry.

( Industry Median: 131.01 vs. SNN: 354.48 )
Ranked among companies with meaningful Days Inventory only.
SNN' s 10-Year Days Inventory Range
Min: 211.88  Med: 274.12 Max: 336.55
Current: 354.48
211.88
336.55
Days Sales Outstanding 79.87
SNN's Days Sales Outstanding is ranked lower than
60% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 68.21 vs. SNN: 79.87 )
Ranked among companies with meaningful Days Sales Outstanding only.
SNN' s 10-Year Days Sales Outstanding Range
Min: 73.2  Med: 88.81 Max: 97.4
Current: 79.87
73.2
97.4

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 2.61
SNN's Dividend Yield is ranked higher than
79% of the 178 Companies
in the Global Medical Devices industry.

( Industry Median: 1.64 vs. SNN: 2.61 )
Ranked among companies with meaningful Dividend Yield only.
SNN' s 10-Year Dividend Yield Range
Min: 0.56  Med: 1.42 Max: 3.57
Current: 2.61
0.56
3.57
Dividend Payout 0.78
SNN's Dividend Payout is ranked higher than
60% of the 108 Companies
in the Global Medical Devices industry.

( Industry Median: 0.39 vs. SNN: 0.78 )
Ranked among companies with meaningful Dividend Payout only.
SNN' s 10-Year Dividend Payout Range
Min: 0.13  Med: 0.33 Max: 4.43
Current: 0.78
0.13
4.43
Dividend growth (3y) 14.40
SNN's Dividend growth (3y) is ranked higher than
77% of the 47 Companies
in the Global Medical Devices industry.

( Industry Median: 3.30 vs. SNN: 14.40 )
Ranked among companies with meaningful Dividend growth (3y) only.
SNN' s 10-Year Dividend growth (3y) Range
Min: -54  Med: 9.65 Max: 19.6
Current: 14.4
-54
19.6
Yield on cost (5-Year) 5.74
SNN's Yield on cost (5-Year) is ranked higher than
91% of the 180 Companies
in the Global Medical Devices industry.

( Industry Median: 1.62 vs. SNN: 5.74 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
SNN' s 10-Year Yield on cost (5-Year) Range
Min: 1.22  Med: 3.10 Max: 4.98
Current: 5.74
1.22
4.98
Share Buyback Rate 0.10
SNN's Share Buyback Rate is ranked higher than
83% of the 206 Companies
in the Global Medical Devices industry.

( Industry Median: -4.00 vs. SNN: 0.10 )
Ranked among companies with meaningful Share Buyback Rate only.
SNN' s 10-Year Share Buyback Rate Range
Min: 23.3  Med: 1.00 Max: -0.6
Current: 0.1

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 57.92
SNN's Price/Tangible Book is ranked lower than
98% of the 261 Companies
in the Global Medical Devices industry.

( Industry Median: 4.35 vs. SNN: 57.92 )
Ranked among companies with meaningful Price/Tangible Book only.
SNN' s 10-Year Price/Tangible Book Range
Min: 4.89  Med: 11.45 Max: 64.44
Current: 57.92
4.89
64.44
Price/Projected FCF 1.95
SNN's Price/Projected FCF is ranked higher than
54% of the 111 Companies
in the Global Medical Devices industry.

( Industry Median: 2.09 vs. SNN: 1.95 )
Ranked among companies with meaningful Price/Projected FCF only.
SNN' s 10-Year Price/Projected FCF Range
Min: 1.04  Med: 2.01 Max: 5.73
Current: 1.95
1.04
5.73
Price/DCF (Earnings Based) 1.89
SNN's Price/DCF (Earnings Based) is ranked lower than
56% of the 16 Companies
in the Global Medical Devices industry.

( Industry Median: 1.69 vs. SNN: 1.89 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.25
SNN's Price/Median PS Value is ranked lower than
60% of the 263 Companies
in the Global Medical Devices industry.

( Industry Median: 1.14 vs. SNN: 1.25 )
Ranked among companies with meaningful Price/Median PS Value only.
SNN' s 10-Year Price/Median PS Value Range
Min: 0.67  Med: 1.18 Max: 1.84
Current: 1.25
0.67
1.84
Price/Graham Number 8.84
SNN's Price/Graham Number is ranked lower than
88% of the 136 Companies
in the Global Medical Devices industry.

( Industry Median: 2.46 vs. SNN: 8.84 )
Ranked among companies with meaningful Price/Graham Number only.
SNN' s 10-Year Price/Graham Number Range
Min: 0.93  Med: 3.85 Max: 10
Current: 8.84
0.93
10
Earnings Yield (Greenblatt) (%) 3.78
SNN's Earnings Yield (Greenblatt) (%) is ranked higher than
69% of the 308 Companies
in the Global Medical Devices industry.

( Industry Median: 0.60 vs. SNN: 3.78 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
SNN' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 2.9  Med: 6.20 Max: 11.4
Current: 3.78
2.9
11.4
Forward Rate of Return (Yacktman) (%) 3.13
SNN's Forward Rate of Return (Yacktman) (%) is ranked lower than
53% of the 99 Companies
in the Global Medical Devices industry.

( Industry Median: 4.14 vs. SNN: 3.13 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
SNN' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: 1.9  Med: 23.40 Max: 72.3
Current: 3.13
1.9
72.3

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:SN..UK, SNNUF.USA, NPWA.Germany, NPW1.Germany,
Smith & Nephew PLC was incorporated on February 17, 1937. The Company develops, manufactures, markets and sells medical devices. The Company is organized into business segments namely Advanced Surgical Devices and Advanced Wound Management. The Advanced Surgical Devices offers Orthopaedic Reconstruction which includes Hip Implants, Knee Implants and ancillary products such as bone cement and mixing systems used in cemented reconstruction joint surgery, Trauma & Extremities consisting of internal and external devices used in the stabilisation of severe fractures and deformity correction procedures, Sports Medicine Joint Repair, which offers surgeons a various instruments, technologies and implants necessary to perform minimally invasive surgery of the joints, Arthroscopy Enabling Technologies which offer healthcare providers various technologies such as fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources and monitors to assist with visualisation inside the joints, radio frequency wands, electromechanical and mechanical blades, and hand instruments for removing damaged tissue. The Advanced Wound Management segment offers Advanced Wound Care includes products for the treatment of acute and chronic wounds, including leg, diabetic and pressure ulcers, burns and post-operative wounds, Advanced Wound Devices consists of traditional and single-use Negative Pressure Wound Therapy and hydrosurgery systems, Advanced Wound Bioactives includes biologics and other bioactive technologies that provide approaches to debridement and dermal repair/regeneration. The Company operates across the world and is subject to legislation, including anti-bribery and corruption and data protection, in each country in which it operates.
» More Articles for SNN

Headlines

Articles On GuruFocus.com
Edwards Lifesciences a Gold Standard in the Market Dec 16 2014 
Sintana Energy Reports on Execution of Drilling Rig Contract Dec 11 2014 
3 Dividend Kings From The U.K. I Love To Buy Aug 21 2014 
Stryker Corporation (SYK) Dividend Stock Analysis Jan 11 2013 
5 Highly Predictable Mid-/Large-Caps with ROC Over 15% Apr 21 2012 
The Best Dividends on April 18, 2012 Apr 18 2012 
5 Healthcare Stocks to Consider Today Mar 21 2012 
medical Feb 29 2012 
Stryker Corp. (SYK) Dividend Stock Analysis Dec 16 2011 
comment on SNN Nov 08 2011 

More From Other Websites
Medical technology firm to 'streamline operations' with new $35M facility Jul 28 2015
The operation of Cernavoda NPP within normal parameters despite the decrease of the level of the... Jul 22 2015
Smith & Nephew acquires Russian distribution and manufacturing business Jul 10 2015
Smith & Nephew buys Russian manufacturing business Jul 10 2015
Smith & Nephew buys Russian manufacturing business Jul 10 2015
Smith & Nephew upgraded by Berenberg Jul 09 2015
Britain's FTSE lifted by gains in mining stocks Jul 09 2015
Smith & Nephew to Partner with Scopis on “Next Generation” Target Guided Surgical Technology... Jul 07 2015
What’s The Best Buy? National Grid plc, Taylor Wimpey plc Or Smith & Nephew plc Jun 26 2015
The Wound Institute® Website Receives Bronze Stevie® Award in 2015 American Business Awards(SM) Jun 25 2015
Medical-Device Maker Zimmer Narrows Revenue Projection Jun 24 2015
Smith & Nephew to acquire Zimmer’s Unicondylar Knee system in US market Jun 24 2015
Smith & Nephew to acquire Zimmer's Unicondylar Knee system in US market Jun 24 2015
Smith & Nephew Receives $99 Million Patent Infringement Payment from Arthrex Jun 17 2015
Smith & Nephew Receives $99 Million Patent Infringement Payment from Arthrex Jun 17 2015
Reconnection of Cernavoda NPP Unit 1 to the National Power Grid Jun 15 2015
Smith & Nephew acquires locally developed software packages Jun 11 2015
Shire Appoints Olivier Bohuon to its Board of Directors Jun 11 2015
Should You Sell Smith & Nephew plc & Buy Petrofac Limited Today? Jun 05 2015
Statement regarding BHR System Jun 04 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK